Hopman Mark 4
4 · Beta Bionics, Inc. · Filed Mar 5, 2026
Insider Transaction Report
Form 4
Hopman Mark
Chief Commercial Officer
Transactions
- Sale
Common Stock
[F1]2026-03-04$11.57/sh−353$4,084→ 139,133 total
Footnotes (1)
- [F1]Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025.
Signature
/s/ Stephen Feider, Attorney-in-Fact|2026-03-05